Diabetes and hypertension: The bad companions

Journal of Hypertension, Supplement

Volumn 15, Issue 2, 1997, Pages

  Epstein, Murray ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Angiotensin converting enzyme inhibitors; Calcium antagonists; Cardiovascular risk factors; Diabetes mellitus; Diabetic nephropathy; Essential hypertension; Kidney failure; Lipid metabolism

Indexed keywords

ANTIHYPERTENSIVE AGENT;

AGING; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONFERENCE PAPER; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE PREDISPOSITION; ESSENTIAL HYPERTENSION; HUMAN; HYPERTENSION; INDUSTRIALIZATION; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL;

DIABETES MELLITUS, TYPE 2; HUMANS; HYPERTENSION; PREVALENCE;

EID: 0030909461     PISSN: 09521178     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (5)

1. Epstein M, Sowers JR: Diabetes mellitus and hypertension. Hypertension 1992, 19:403-418.
2. The National High Blood Pressure Education Program Working Group (Chair, James R. Sowers): National high blood pressure education program working group report on hypertension in diabetes. Hypertension 1994, 23:145-158.
3. Sowers J, Epstein M: Diabetes mellitus and associated hypertension, vascular disease, and nephropathy: an update. Hypertension 1995, 26: 869-879.
4. Zatz R, Brenner BM: Pathogenesis of diabetic microangiopathy: the hemodynamic view. Am J Med 1986, 80:443-453.
5. Vigstrup J, Mogensen CE: Proliferative diabetic retinopathy: at risk patients identified by early detection of microalbuminuria. Acta Ophthalmol 1985, 63:530-534.